The most recent Success stories from EU Research. Select a theme or country from the menus on the left to see more articles
Tick (check) box to add article to PDF "basket"
To answer the question of why diabetic patients are more susceptible to developing tuberculosis, the EU-funded TANDEM project linked leading European laboratories with field sites in TB-endemic countries such as Indonesia.
Published: 13 November 2018
Tuberculosis (TB) and tobacco-related lung disease kill millions around the world every year. What if programmes to stop one could target the other, too? An international initiative, including partners from Pakistan, Bangladesh and Nepal is doing just that, blending effective yet affordable tobacco cessation strategies with TB control programmes.
Published: 27 June 2018
Tuberculosis is a silent killer. According to the World Health Organisation more than 10 million people were diagnosed with the disease in 2016. The previous year, some 1,8 million people died from it making TB one of the top ten main causes of death globally.
Published: 4 December 2017
New vaccines could be developed more quickly and be better targeted to specific age groups, thanks to EU-funded research. A five-year project has been studying novel immunisation technologies, boosting international efforts in vaccine research.
Published: 16 February 2016
An EU-funded project has accelerated the development of vaccines for diseases such as Lyme disease, malaria, tuberculosis, dengue, influenza, mumps, whooping cough, pneumonia, HIV, and two types of cancer. Their work could lead to new, more effective vaccines - potentially saving millions of people from disease.
Published: 25 March 2015